The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NNCSF's RSI Oscillator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on December 26, 2024. You may want to consider a long position or call options on NNCSF as a result. In of 47 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for NNCSF just turned positive on December 27, 2024. Looking at past instances where NNCSF's MACD turned positive, the stock continued to rise in of 35 cases over the following month. The odds of a continued upward trend are .
NNCSF moved above its 50-day moving average on December 30, 2024 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for NNCSF crossed bullishly above the 50-day moving average on January 08, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NNCSF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.268) is normal, around the industry mean (23.424). P/E Ratio (138.889) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (10.020) is also within normal values, averaging (41.167).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NNCSF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SMPIX | 42.86 | 1.93 | +4.72% |
ProFunds Semiconductor UltraSector Inv | |||
GMOEX | 23.42 | 0.17 | +0.73% |
GMO Emerging Markets III | |||
THOCX | 35.38 | 0.23 | +0.65% |
Thornburg Global Opportunities C | |||
ANONX | 23.73 | 0.07 | +0.30% |
American Century Small Cap Growth I | |||
HIAHX | 16.55 | -0.11 | -0.66% |
Hartford Healthcare HLS IA |
A.I.dvisor tells us that NNCSF and ASAPF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NNCSF and ASAPF's prices will move in lockstep.
Ticker / NAME | Correlation To NNCSF | 1D Price Change % | ||
---|---|---|---|---|
NNCSF | 100% | N/A | ||
ASAPF - NNCSF | 21% Poorly correlated | N/A | ||
NHNKY - NNCSF | 8% Poorly correlated | +43.58% | ||
ODYY - NNCSF | 1% Poorly correlated | N/A | ||
NHNKF - NNCSF | 0% Poorly correlated | N/A | ||
NVYTF - NNCSF | 0% Poorly correlated | N/A | ||
More |